OverviewSuggest Edit

FORMA Therapeutics is a biopharmaceutical company intended for the discovery, development, and commercialization of transformative medicines. It has two core product candidates for development: FT-4202 for the treatment of sickle cell disease, or SCD, and other hemoglobinopathies, and FT-7051 for the treatment of metastatic castration-resistant prostate cancer, or mCRPC.

HQWatertown, US
Employee Ratings4

Latest Updates

Employees (est.) (Apr 2020)77
Share Price (Aug 2020)$34 (-1%)
Cybersecurity ratingAMore

Key People/Management at FORMA Therapeutics

Frank D. Lee

Frank D. Lee

Chief Executive Officer, Director
David Cook

David Cook

Senior Vice President, Chief Scientific Officer
Patrick Kelly

Patrick Kelly

Senior Vice President, Chief Medical Officer
Jeannette Potts

Jeannette Potts

Senior Vice President, General Counsel & Corporate Secretary
Todd Shegog

Todd Shegog

Senior Vice President, Chief Financial Officer
Mary Wadlinger

Mary Wadlinger

Senior Vice President, Corporate Affairs and Chief Human Resources Officer
Show more

FORMA Therapeutics Office Locations

FORMA Therapeutics has an office in Watertown
Watertown, US (HQ)
500 Arsenal St #100
Show all (1)

FORMA Therapeutics Financials and Metrics

FORMA Therapeutics Revenue

Market capitalization (12-Aug-2020)


Closing stock price (12-Aug-2020)

FORMA Therapeutics's current market capitalization is $1.4 b.
Show all financial metrics

FORMA Therapeutics Cybersecurity Score

Cybersecurity ratingPremium dataset



SecurityScorecard logo

FORMA Therapeutics Online and Social Media Presence

Embed Graph

FORMA Therapeutics News and Updates

Forma Therapeutics sets terms for IPO, could raise up to $212 million

Forma Therepeutics set terms for its initial public offering, in which the biopharmaceutical company focusing on treatments for hematologic diseases and cancers could raise up to $211.8 million. The company is offering 11.8 million shares in the IPO, which is expected to price between $16 and $18 a…

FORMA Therapeutics Frequently Asked Questions

  • When was FORMA Therapeutics founded?

    FORMA Therapeutics was founded in 2008.

  • Who are FORMA Therapeutics key executives?

    FORMA Therapeutics's key executives are Frank D. Lee, David Cook and Patrick Kelly.

  • How many employees does FORMA Therapeutics have?

    FORMA Therapeutics has 77 employees.

  • Who are FORMA Therapeutics competitors?

    Competitors of FORMA Therapeutics include Kura Oncology, MyoKardia and Alkahest.

  • Where is FORMA Therapeutics headquarters?

    FORMA Therapeutics headquarters is located at 500 Arsenal St #100, Watertown.

  • Where are FORMA Therapeutics offices?

    FORMA Therapeutics has an office in Watertown.

  • How many offices does FORMA Therapeutics have?

    FORMA Therapeutics has 1 office.